
Century Therapeutics (IPSC)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Century Therapeutics (IPSC) Stock
Start investing in Century Therapeutics (IPSC)
About Century Therapeutics (IPSC)
Market cap | $48.14M |
Today's volume | 445.29K |
Revenue (TTM) | $114.9M |
Avg. daily volume | 858.07K |
EBITDA (TTM) | -$16.62M |
Open | $0.55 |
Price / earnings ratio | -1.97x |
Today's range | $0.54 - $0.56 |
Debt / equity | 21.91x |
52 week range | $0.34 - $3.29 |
5 year debt / equity | 19.16x |
Beta (LTM) | 1.44x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 11.7x |
Ex-dividend date | — |
Next earnings | Aug 7, 2025 |
Dividend payable date | — |
Century Therapeutics Stock Rating
Century Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy IPSC stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in IPSC stock
Navigate to the Explore page. Then, type IPSC into the search bar. When you see IPSC stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased IPSC stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Century Therapeutics Stock Earnings
The value each IPSC share was expected to gain vs. the value that each IPSC share actually gained.
Century Therapeutics (IPSC) reported Q1 2025 earnings per share (EPS) of $0.89, beating estimates of -$0.31 by 387.10%. In the same quarter last year, Century Therapeutics's earnings per share (EPS) was -$0.45. Century Therapeutics is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of $0.